Technical Analysis for TSBX - Turnstone Biologics Corp.

Grade Last Price % Change Price Change
F 3.58 -4.28% -0.16
TSBX closed down 4.28 percent on Friday, September 22, 2023, on 19 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -4.28%
New 52 Week Low Weakness -4.28%
Wide Bands Range Expansion -4.28%
Oversold Stochastic Weakness -4.28%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Turnstone Biologics Corp. Description

Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes

Is TSBX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 13.2
52 Week Low 3.57
Average Volume 80,529
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 7.57
10-Day Moving Average 4.67
Average True Range 1.00
RSI (14) 21.88
ADX 31.18
+DI 10.15
-DI 33.35
Chandelier Exit (Long, 3 ATRs) 9.17
Chandelier Exit (Short, 3 ATRs) 6.56
Upper Bollinger Bands 13.75
Lower Bollinger Band 1.40
Percent B (%b) 0.18
BandWidth 162.96
MACD Line -1.96
MACD Signal Line -1.62
MACD Histogram -0.3397
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.12
Resistance 3 (R3) 4.18 4.05 4.03
Resistance 2 (R2) 4.05 3.92 4.03 4.00
Resistance 1 (R1) 3.82 3.83 3.76 3.76 3.97
Pivot Point 3.69 3.69 3.66 3.67 3.69
Support 1 (S1) 3.46 3.56 3.40 3.40 3.19
Support 2 (S2) 3.33 3.47 3.31 3.16
Support 3 (S3) 3.10 3.33 3.13
Support 4 (S4) 3.04